[ CYPHER CODE #464 ]
Officials only tell the truth when the lie has outlived its usefulness.

[ CYPHER CODE #465 ]
When the FDA chief hints at lab-born pathogens, he’s not informing. He’s signaling.

[ CYPHER CODE #466 ]
If HIV and Lyme were engineered, the real question isn’t origin. It’s motive.

BRIEFING

Grant here. The head of the FDA just admitted something big, and what he said isn’t just a confession, but it’s a signal. Marty Makary told the PBD Podcast that two of the most consequential diseases of the last century may trace back to labs. Let’s break it down.

During that interview, he didn’t speak in hypotheticals. He claims that HIV may have come from a lab in Africa, and he pointed directly at Plum Island’s Lab 257 as the likely origin of Lyme disease. He supported the claim by referencing post-WWII bioweapons work tied to Erich Traub, who joined U.S. biodefense work after the war.

His comments on HIV aren’t backed yet by 100% bulletproof conclusive evidence, but that isn’t the point of this moment. The point is that a high-ranking official is now saying out loud what institutions have spent decades avoiding. That tells you the narrative is shifting, even if the science isn’t settled.

And when a sitting FDA commissioner decides to put two politically sensitive diseases on the table and frame both as potential products of laboratory research, the public should be listening with full attention.

SOURCE

HIV: ā€˜It May Very Well Have Come from a Lab in Africa’

Makary described how mainstream institutions avoid uncomfortable evidence about HIV’s beginnings.

When pressed on the origin of AIDS, he said the following:

ā€œThey explore a non-traditional narrative, which has not gotten the attention it deserves. And that is that it may very well have come from a lab in Africa.ā€

Makary is one of the most publicly visible medical figures in the United States—Hopkins professor, long-time NIH-funded surgeon, and prominent FDA advisor.

His admission directly contradicts decades of official insistence that HIV was unquestionably a zoonotic spillover.

Lyme Disease: ā€˜It came from Lab 257 on Plum Island’

When the conversation turned to Lyme disease—which afflicts millions of Americans—Makary said:

ā€œI can tell you with a high degree of probability. It came from Lab 257 on Plum Island just outside of Connecticut, 25 miles from Lyme, Connecticut, where the first case was described.ā€

He then explained how he knows:

ā€œFirst of all, you can read the bookĀ Bitten.Ā It’s a great book.ā€

And he explained who the U.S. brought to Plum Island after WWII:

ā€œWhen the Nazi war criminal doctors were executed in Nuremberg, at least one of them was spared and brought to the United States so that his mind could be used by the US military for so-called Biodefense. And they put him on Plum Island and he had said very openly that he believed an incredible form of biowarfare was infecting ticks. And that that’s what Lyme disease is.ā€

Makary is referring to the notorious Erich Traub, the Nazi bioweapons scientist recruited by U.S. military intelligence.

ā€œA bunch of mad scientists doing things… How many physicians know that it came from Lab 257? Approximately 1%.ā€

He ended with the warning that the public health establishment refuses to confront:

ā€œJust because you can do something doesn’t mean you should do it. And sometimes we can cause more harm than we can good by messing with Mother Nature.ā€

DEBRIEFING

So zooming out and looking at this overall, Makary didn’t just float two theories, but he exposed the pattern behind how these stories are managed. When top officials discuss the origins of the lab, it's not just the claim that matters, but also the timing. Institutions realistically only open a door like this when the old narrative can’t carry on any longer.

HIV and Lyme aren’t being paired by accident. One is global, the other is domestic, and connecting them establishes a clear path from foreign research to U.S. biodefense efforts, a pipeline that very few likely want to be named. That’s why his comments matter more than their certainty. Markary clearly demonstrates to the public where these lines connect.

And here's the part most people will miss: once a top authority figure says two diseases may trace back to labs, the conversation changes. You stop debating outbreaks and start examining the entire system. And when the system becomes the focus, the story isn’t just about viruses anymore, but it’s about who builds them, who protects the narrative around them, and why silence has held this long.

NOW YOU KNOW

When the FDA shifts, the story beneath it is already moving.